✦ LIBER ✦
CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies: Mavroudis D, Read E, Cottler-Fox M, et al. Blood 88:3223–3229, 1996
- Book ID
- 114268673
- Publisher
- Elsevier Science
- Year
- 1997
- Tongue
- English
- Weight
- 123 KB
- Volume
- 11
- Category
- Article
- ISSN
- 1532-9496
No coin nor oath required. For personal study only.